Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,20%
1 108,23
-2,24
-0,20%
—1 110,471 107,751 111,341 093,81——
SIXC
Communications
SIXC
Communications
SIXC
+0,26%
605,63
+1,56
+0,26%
—604,07604,07606,04600,91——
SIXE
Energy
SIXE
Energy
SIXE
+0,70%
1 209,95
+8,46
+0,70%
—1 201,491 205,921 215,311 201,02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,40%
1 758,23
-7,07
-0,40%
—1 765,301 764,031 764,031 736,40——
SIXM
Financials
SIXM
Financials
SIXM
+0,72%
634,94
+4,52
+0,72%
—630,42630,34636,69626,03——
SIXR
Staples
SIXR
Staples
SIXR
+1,30%
852,37
+10,92
+1,30%
—841,45843,60858,11840,11——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,01%
218,85
+0,020
+0,01%
—218,83218,83219,32217,33——
SIXT
Technology
SIXT
Technology
SIXT
-1,50%
3 528,49
-53,74
-1,50%
—3 582,233 550,603 562,623 447,78——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,10%
914,82
+0,93
+0,10%
—913,89912,75918,12906,67——
SIXV
Health care
SIXV
Health care
SIXV
+1,93%
1 472,27
+27,94
+1,93%
—1 444,331 446,871 480,741 446,30——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,93%
2 390,61
-22,35
-0,93%
—2 412,962 403,992 411,412 373,90——
ONCY:NASDAQ
Oncolytics Biotech Inc
USD 0,90
-0,03%
(-0,00030) 1D
USD 0,90
+0,02% (+0,00020)
After hours
Closed: 12 Mei, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ONCY...
Open
USD 0,88
High
USD 0,92
Low
USD 0,88
Mkt. cap
105,32 m
Avg. vol.
1,21 m
Volume
575,95 k
52-wk high
USD 1,51
52-wk low
USD 0,33
EPS
-USD 0,30
Beta
1,02
Shares outstanding
116,13 m
No. of employees
29
News stories
From sources across the web
Profile
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Kanada
Sector-
Websiteoncolyticsbiotech.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Des. 2024
Mrt. 2025
Jun. 2025
Sep. 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
4,08 m
2,81 m
7,52 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
2,92 m
2,90 m
6,32 m
Operating expense
-
7,00 m
5,71 m
13,84 m
Total operating expenses
-
7,00 m
5,71 m
13,84 m
Operating income
-
-7,00 m
-5,71 m
-13,84 m
Other non operating income
-
240,00 k
-196,00 k
-1,05 m
EBT including unusual items
-
-6,69 m
-6,08 m
-14,65 m
EBT excluding unusual items
-
-6,69 m
-6,08 m
-14,65 m
Income tax expense
-
-
85,00 k
-252,00 k
Effective tax rate
-
-
-1,40%
1,72%
Other operating expenses
-
-
-
-
Net income
-
-6,69 m
-6,16 m
-14,40 m
Net profit margin
-
-
-
-
Earnings per share
-0,10
-0,08
-0,07
-0,14
Interest and investment income
-
123,00 k
104,00 k
100,00 k
Interest expense
-
-
-
-
Net interest expenses
-
123,00 k
104,00 k
100,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-6,97 m
-5,68 m
-13,82 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer